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ABSTRACT  H36 is a species-specific,  cell-surface antigen on differentiating newborn rat skeletal 
myoblasts  and  myogenic  lines.  This  membrane  antigen  has been defined  by a  monoclonal 
antibody  raised  by  the  fusion  of SP 2/0-Ag14  myeloma  cells  with  spleen  cells  from  mice 
immunized  with  myotubes  derived  from  the  myogenic  E63  line.  H36  antigen,  isolated  by 
immunoaffinity  chromatography, is comprised  of two polypeptides with  apparent molecular 
weights of 98,000 and 117,000.  Fluorescence  photometry and radioimmunoassays  have been 
used to follow quantitative and topographic changes in the H36 determinant during myogen- 
esis. H36 is present at a basal level on replicating myoblasts;  it increases on prefusion myoblasts 
and persists on myotubes. At or near the time of prefusion, it becomes concentrated between 
adjacent aligned  myoblasts  and  localized  on  membrane  "blebs".  H36  is  present  on  both 
skeletal  and cardiac cells  but absent from a variety of cells that include fibroblasts,  neuronal 
cells, and smooth  muscle.  There are ~4 ×  10  s determinants per myoblast, and the Ka of the 
antibody is 3.8 x  10  a literslmol. The distributions of H36 on the top and attached surfaces of 
myoblasts and myotubes are distinct, which suggests localized specialization of these surfaces. 
H36  is  an  integral  membrane  component  and  upon  cross-linking,  it  associates  with  the 
detergent-insoluble  cytoskeletal  framework.  Inhibition  of myogenesis  by 5-bromodeoxyuri- 
dine  or  by  calcium  deprivation  prevents  the  developmentally  associated  changes  in  the 
expression of H36. H36 is also absent or markedly reduced on the fu- and Amal02 develop- 
mentally  defective  mutant  myoblast  lines.  We  conclude  that  H36  is  a  muscle-specific, 
developmentally regulated cell-surface antigen that may have a role in myoblast differentiation 
and that can be used to determine the embryonic lineages of skeletal and cardiac muscle. 
The fusion of mononucleate myoblasts to form multinucleate 
fibers is a  striking morphologic event that is unique to the 
differentiation of skeletal  muscle.  The  facility with  which 
myoblasts can be isolated and grown has made this stage of 
muscle development readily amenable to experimental anal- 
ysis,  and  the  differentiation of both primary explants and 
cloned myogenic cell lines grown in  vitro rather faithfully 
mimics in vivo development. As such, these cells have pro- 
vided a convenient model system in which to examine devel- 
opmental regulation, genetic expression, and biochemical dif- 
ferentiation, and, in particular, the synthesis and assembly of 
distinct isoforms of myofibrillar proteins and isozymes (for 
recent  reviews,  see  references  l0  and  37).  Ironically,  the 
characteristic fusion  of myoblasts, which  has  provided the 
hallmark  for  defining  myogenic cells,  is  one  of the  least 
understood events in this stage of  development. Furthermore, 
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attempts  to  study  earlier  stages  of myogenesis have  been 
stymied by the lack of distinct markers with which to identify 
and isolate those cells that develop into fusing myoblasts. One 
approach recently taken to resolve these gaps in our under- 
standing of  myogenesis has been to use monoclonal antibodies 
to define the events on the cell membrane that accompany 
myogenesis 07, 25,  26,  26a, 31, 48, 49), to identify specific 
molecular species  with distinct functional capacities of the 
cell  (12,  16,  35),  and  to  explore  cell  surface  markers  of 
myogenic cells to identify the myogenic lineage. 
We report here a cell surface antigen denoted H36 that is 
present on rat skeletal muscle and is defined by a monoclonal 
antibody raised in response to immunization with myotubes. 
We describe the quantitative and topographic stage-specific 
changes in H36 antigen that accompany normal development. 
Analyses of mutant myoblasts and other cell types, and rood- 
1977 ulation of expression of H36 upon inhibition of myogenesis 
by 5-bromodeoxyuridine (BrdUrd)  l and calcium deprivation, 
lead us to conclude that H36 is a muscle-specific cell-surface 
antigen that may be important to myoblast fusion and of use 
in defining the myogenic lineage. 
MATERIALS AND  METHODS 
Cell Lines:  E63, a myogenic clone of L8 rat skeletal myoblasts, and the 
developmentally defective fu- lines flu-l, -3, -4, -5, and -15,  mutants of L8) 
were  isolated  in  this laboratory  (22,  23).  L6  myoblasts and the nonfusing 
amanitin-resistant mutant Amal02 (7, 45) were otained from Dr. M. Pearson 
(E. 1. DuPont, Wilmington, DE). MMI4 mouse myoblasts were obtained from 
Drs. T. Linkhart and S. Hauscbka (University of Washington, Seattle,  WA), 
Rat-1 fibroblasts from Dr..1. Wyke (Imperial Cancer Research Fund, London, 
England),  and FRECl2  rat fibroblasts  and NRK rat kidney line from Dr. S. 
Rasheed (University of Southern  California,  Los  Angeles,  CA).  With  the 
exception of MMI4, these cell lines were maintained in Dulbecco's modified 
Eagle's medium (DME) supplemented with 10% horse serum (HS),  100 U/ml 
penicillin,  100 ;zg/ml streptomycin, and  10 #g/ml kanamycin. MMI4 myo- 
blasts were grown on gelatin-coated dishes in DME supplemented with  15% 
HS, 3% chick embryo extract, 1% nonessential amino acids, and antibiotics as 
above. SP 2/0-Agl4 myeloma cells (42) were obtained from the Cell Distribu- 
tion Center at the Salk Institute (La Jolla,  CA) and were grown in DME with 
10% heat-inactivated fetal  bovine serum (FBS) and antibiotics. All cell  lines 
were grown in a humidified atmosphere containing 10% CO2. Growth media, 
sera, and other supplements were purchased from Gibeo Laboratories (Grand 
Island, NY). 
Primary Cell Cultures:  Skeletal  myoblasts from  newborn Sprague 
Dawiey rat hind limbs (Holtzman Co., Madison, WI) were prepared either by 
Dr. J. Thompson (University of  lUinois, Urbana, IL), or in our lab as previously 
described (36).  Fibroblast cultures were obtained from the same preparations 
by selective plating and subeulturing. Kidney and liver cultures were prepared 
by trypsin dissociation of tissue from newborn rots; both cultures contained 
colonies of proliferating cuboidal, epitheliaMike  cells. Trypsin dissociation of 
preparturition rat uterus yielded cultures in which three morphologically dis- 
tinct cell types were observed:  epitheliaMike  colonies, fibroblast-like  cells, and 
narrow bipolar cells which, on proliferation, formed parallel arrays. Additional 
smooth-muscle  cultures were obtained from 3-d-old rats, from explants ofaorta 
and from trypsin-treated stomach and duodenum. These primary cultures were 
maintained in DME with 5% HS, 5% FBS, and antibiotics. 
Cardiac myoblasts were prepared from heart ventricles of 5-d-old rats by the 
method of Kasten (2 l) and were grown in DME supplemented with 10% FBS, 
1% nonessential amino acids, and antibiotics. Human skeletal myoblasts were 
prepared by using the procedure of Blau and Webster (2) and were grown on 
collagen-coated  dishes in Ham's Fl0 medium supplemented with 20%  FBS, 
0.5%  chick  embryo extract,  and  antibiotics. Clones were  obtained  by the 
method of limiting dilution  using conditioned  medium. All  clones formed 
myotubes when the medium was replaced  with DME that contained 10% HS. 
Chick  embryo  myoblasts were  dissociated from  thigh muscle of  12-d-old 
embryos by the vortex method of Bullaro and Brookman (3)  and grown in 
medium 199 with 10% HS, 2% chick embryo extract, and antibiotics. Media 
and supplements  were purchased from Gibeo Laboratories. 
Cultures of rat brain from preparturition fetuses were  kindly provided by 
Dr. J. Weyhenmeyer  (University of Illinois, Urbana, IL) (52). 
Production of Monoclonal Antibody H36:  8-wk Balb/cV mice 
(19) were immunized at 7-8-d intervals with four intraperitoneal injections of 
E63 m yotubes by using one 100-ram dish of cells per mouse for each injection. 
Cells were harvested with a rubber policeman and injected in 0.2 ml Dulbecco's 
phosphate-buffered  saline, pH 7.5 (DPBS). 3 d after the fourth injection, spleens 
from two  mice were excised,  and a  single-cell  suspension was prepared  as 
previously described (31). SP 2/0-Ag14 cells, grown for several generations in 
20 ug/ml 8-azaguanine before use, were harvested in the log phase of growth. 
Fusion of spleen and myeloma cells was done by the method of Kennett et al. 
1Abbreviations  used in this paper.  BrdUrd,  5-bromodeoxyuridine; 
DME, Dulbecco's modified Eagle's medium; DPBS, Dulbecco's phos- 
phate-buffered saline; FBS, fetal bovine serum; FITC-RAMIg, rabbit 
anti-mouse  immunoglobulin conjugated  with  fluroescein  isothio- 
cyanate;  HAT,  a  selective medium  that  contains  DME  with  18% 
FBS,  l 1%  NCTC  135,  15  ~g/ml hypoxanthine, 0.2 tLg/ml aminop- 
terin, 8 t~g/mi thymidine, 150 #g/ml oxaloacetate, 50 ~g/ml pyruvate, 
8  #g/ml bovine  insulin,  nonessential amino acids,  and  antibiotics; 
HS,  horse serum; HT.10,  HAT medium without aminopterin and 
with only 10% FBS; IF, immunofluorescence. 
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(27) using 35% polyethylene glycol-l,000 as previously described (31).  Before 
cloning, hybridomas were  maintained in HAT selective  medium (DME with 
18% FBS,  11% NCTC 135, 15 tzg/ml hypoxanthine, 0.2 #g/ml aminopterin, 9 
~g/ml thymidine, 150 #g/ml oxaloacetate, 50 pg/ml pyruvate, 8 ~g/ml bovine 
insulin, nonessential amino acids,  and antibiotics).  Hybridoma culture fluids 
were screened by indirect immunofiuorescence  (IF) for antibody reactive  with 
live E63  myotubes. Hybridoma H36 was cloned in 0.24%  agarose (SeaKem, 
Marine Colloids,  FCM Corp., Rockland, ME) that contained 50% conditioned 
medium. Antibody was collected  from cells in log phase in HT.10 medium 
(HAT,  without aminopterin and with  only  10%  FBS),  supplemented with 
0.02%  sodium azide,  and stored at -20"C.  8-Azaguanine and biochemicals 
used to supplement HAT and HT. 10 were obtained from Sigma Chemical Co. 
(St. Louis, MO). 
Ascites fluid was obtained by the injection of 10 x  106 hybridoma cells into 
the peritoneal cavity of Balb/cV mice primed with pristane (Aldrich Chemical 
Co.,  Milwaukee,  WI).  H36 antibody was purified from ascites fluid by ion 
exchange chromatography on DEAE-Sephacel  (Bio-Rad Laboratories,  Rich- 
mond,  CA)  and  precipitation  with  ammonium sulfate (50%  vol/vol  final 
concentration). The antibody was >95% pure as determined by densitometric 
scanning of SDS  14%  polyacrylamide gels  (30).  Transferrin was the  only 
detectable contaminant in the preparation, and excess unlabeled transferrin 
added to iodinated H36 antibody had no effect on the binding of the immu- 
noglobulin to  E63  cells.  H36  is an IgGl,  kappa-chain immunoglobulin, as 
determined by radial  immunodiffusion and IF using light-chain and subclass- 
specific antibodies (Litton Bionetics,  Kensington, MD). 
Indirect  Immunofluorescence:  Cells  were  grown  on  acetone- 
washed 18-mm No.  1 glass coverslips coated with collagen (for human and rat 
primary myoblasts) or gelatin in 60-ram dishes. E63 myoblasts were seeded at 
2.75  x  l0  s cells/60-mm dish. After incubation, the cells were  washed three 
times with serum-free medium, and 40 ~1 of hybridoma culture fluid buffered 
with I0 mM HEPES, pH 7.3,  was placed on each coverslip.  In some experi- 
ments, ascites fluid or purified antibody, diluted with DPBS, was used. SP 2/ 
0-Agl4 culture medium or ascites fluid and purified normal mouse immuno- 
globulin were used as negative controls. After 30 min, cells were quickly rinsed, 
then washed four times, each for  10  min, with DPBS.  The cells were  then 
reacted with a  1:30 dilution of purified rabbit anti-mouse immunoglobulin 
conjugated with  fluorescein isothiocyanate (FITC-RAMIg)  in  DPBS,  then 
washed as above. RAMIg (Miles Scientific  Div., Naperville,  IL) was absorbed 
with 5 vol HS for 60 min at 5"C before the assay. For the initial characterization 
of H36 determinant on  E63  cells  and its quantitation by photometry, the 
antibody reactions were carried out at 5"C to minimize changes from the native 
distribution. In subsequent experiments, antibody reactions were conducted at 
room temperature. 
After reaction with antibodies, the cells were fixed  for  l0 min with 95% 
ethanol, and the coverslips were mounted in glycerol/PBS  (9:1) pH 8.5, and l0 
mM p-phenylenediamine (Eastman  Kodak  Co.,  Rochester,  NY)  to  retard 
photohleaching (20) and were sealed with Flo-Texx (Lerner Labs, New Haven, 
CT). Huorescence was viewed  by use of a  Zeiss Universal microscope (Carl 
Zeiss, Inc., Thornwood, NY) with epiillumination optics, HBO 200-W mercury 
lamp, KPS00 and KP490 excitation filters, and LP525 barrier filter. Photometry 
was done using  a Jena photomultiplier and 110 EMI photometer. The response 
of this system to F1TC  is linear over the range of values obtained (26a).  By 
using the Neofluar 40x  objective,  a  field  of 20-22 ~m was measured. The 
photometer was zeroed  on the negative control in each experiment. Kodak 
Ektachrome 400 film was used at an exposure index of 800. 
Quantitation  of Antibody Binding, 5ires:  Antibodybindingsites 
were quantitated by (a) increasing the concentration of radiolabeled  antibody 
and (b) diluting a fixed concentration of radiolabeled  antibody with increasing 
concentrations of unlabeled antibody to determine the amount of antibody 
required for 50%  inhibition of binding of ml. In both procedures, purified 
immunoglobulin was radiolabeled  with  ~2~I by  a  modification (31)  of the 
chloramine T  method (15),  to  a  specific  activity of  1-10  uCi/ug protein. 
Antibody incubations were done in triplicate,  in 96-well  microtiter plates,  in 
100 ~tl/well DME +  5 mg/ml BSA +  10 mM HEPES,  pH 7.4, at 37"C for 4 h. 
After incubation, the cells were washed four times, each for 10 rain, with DPBS, 
then extracted twice with 50 ~1 0.3 N NaOH. Cell lysates were absorbed with 
cotton swabs and counted in a gamma counter. 
Creatine  Kinase Activity and  fusion:  Creatine  kinase specific 
activity was determined by the monitoring of the conversion of NADP to 
NADPH at 340 nm in the enzyme-coupled hexokinase-glucose-6-phosphate 
dehydrngenase reaction  as  previously described  (22).  Myoblast fusion was 
scored on cultures fixed in 70% methanol and stained with 4% glemsa. At least 
ten fields were scored per coverslip. 
Anti-actin  Antibody:  Monoclonal anti-muscle actin antibody, B4, 
was kindly provided by Dr. J.  Lessard (University of Cincinnati, Cincinnati, 
OH) (33). Extraction of Cells with  1% Triton X-lO0:  Cells  were washed 
twice in DPBS and extracted for 4 min at 4"C with 100 mM KC1, 3 mM MgC12, 
l mM CaCl2, 300 mM sucrose, 1% Triton X-100, 1 mM phenylmethylsulfonyl 
fluoride,  l0 mM HEPES, pH 6.8 as previously reported (25). 
Isolation of H36 Antigen:  E63 cells grown to subconfluency on two 
150-ram plates were labeled for 18 h with 8 ml methionine-free DME supple- 
merited with  10%  HS previously dialyzed against DPBS, 20 #M methionine, 
and 2.5  mCi  [35S]methionine (l,000 Ci/mmol, Amersham Corp.,  Arlington 
Heights, IL). Cells were grown in two 150-mm plates and labeled with ~2Sl (2 
mCi/mmol, Amersham Corp.) by the lactoperoxidase-glucose oxidasc method 
(34) when an estimated  10% of nuclei were in myotubes. The cells were then 
washed three times with DPBS and incubated at 20"C for 45 rain with 7 ml of 
DPBS that contained  0.02% NAN3, 0.01% BSA, 0.01% gelatin,  and  50  /~g 
purified H36 antibody.  The excess antibody  was then removed and the H36 
antigen-antibody  complex was extracted with 250 mM KCI, l  mM CaCl2, 3 
mM MgC12, l0 mM HEPES pH 7.4, 200 mM sucrose, l0 mM CHAPS (Sigma 
Chemical  Corp.)  (41), 50  mM  phenylmethylsulfonyl  fluoride,  1%  Trasylol 
(Sigma Chemical Corp.), 0. 1% BSA, and 0.02% NaN3 (buffer A) for l0 min at 
4"C with two successive 7-ml aliquots.  The extract was then centrifuged for 5 
min at 4"C at 7,800 g. The supernatant was then sequentially passed through 
l-ml columns of Affl-gel l0 (Bio-Rad Laboratories), Affi-gel l0 coupled with 
purified  mouse immunoglobulin,  and Affi-gel 10 coupled with RAMIg. The 
three columns were initially equilibrated  with buffer A. After addition  of the 
extract,  the columns were eluted  with buffer A, then with buffers B (0.5 M 
NaC1, 0.05 M HEPES pH 8.0, l mM ED'I:A, and l0 mM CHAPS) and C (0.15 
M NaCl, 0.05 M HEPES pH 8.0, l0 mM CHAPS, and 0.1% SDS), as adapted 
from Schneider  et al. (38). All washes were continued  until  no radioactivity 
could be detected in the effluents. Each column was then eluted with 0.05 M 
diethylamine,  pH I 1.3, and 10 mM CHAPS. These eluents were made pH 7.6 
with 0.5 M NaH2PO4, and dialyzed against  10 mM HEPES pH 7.6 and re-run 
on fresh columns of the same Affl-gel l0 complex as that from which they were 
eluted. The eluents  from the second set of columns were dialyzed against  5 
mM Tris-HCI, pH 7.5, 0.01% SDS and concentrated  10-fold in a Savant speed 
vac concentrator  (Savant  Instruments, Inc., Hicksville, NY).  Aliquots of the 
concentrates  were  electrophoresed  in  a  1.2-mm  thick  7-20%  gradient  of 
polyacrylamide in SDS-Tris-glycine  buffer (30) for 7 h at 20 mA. Molecular 
weight markers  were included  in additional  aliquots of the samples. The gel 
with [3SS]methionine-labeled samples was treated with Enlightning (New Eng- 
land Nuclear, Boston, MA) for 15 min, dried, and exposed to Kodak XAR-5 
film for 2 wk. The gel with J25I-labeled samples was dried and exposed to Kodak 
XAR-5 in a cassette that contained an intensifying screen, for 1 wk. 
RESULTS 
We have used IF analysis and photometry on single cells as 
well as radioimmunoassays to study and quantitate the expres- 
sion and topography of H36 antigen. Indirect IF of H36 was 
done by using cells of myogenic and nonmyogenic origins; 
both cell lines and  primary cultures were screened. In this 
assay,  live cells  are  reacted with  the  primary  and  fluoro- 
chrome-labeled antibodies at 5"C; under these conditions, the 
cell is impermeable to antibody, and only cell surface antigens 
are detected. H36 antibody bound to live cells at  5"C also 
reacts with RAMIg covalently bound to polyacrylamide  beads 
(3-l0/zm diameter), thus confirming the cell surface localiza- 
tion of the antigen. 
Cell and Species Specificity of H36  Antigen 
H36 is present on the L8E63 and L6 lines of rat myoblasts 
and on myoblasts from thigh muscle of newborn rats (Fig.  1; 
Table I). This antigenic determinant is not on skeletal myo- 
blasts or myotubes of human or chick origin, and it is not on 
the MM 14 line of myogenic mouse cells. 
Expression of H36 appears to be highly restricted to my- 
ogenic cells. In mixed cultures of primary newborn rat myo- 
blasts  and  fibroblasts, the  fibroblasts do not stain  (Fig.  l). 
Additional  sources of rat  fibroblasts,  either cell lines (e.g., 
FREC12 and Rat-l  cells),  or in explants of other tissues,  or 
further passages  of fibroblasts from myoblast explants, were 
uniformly negative for H36 (Table I). Of particular interest, 
five developmentally defective fu- mutants derived from the 
myogenic L8 line were also negative for H36 in IF analyses; 
the origins and properties of these mutants were previously 
reported (22, 23). In contrast, other antigens on E63 myoblasts 
that are identified by additional monoclonal antibodies are 
not  uniformly absent  on  the  fu-  lines  (26a).  H36  is  also 
markedly reduced on the Amal02 nonfusing mutant of rat 
L6 myoblasts and absent on early passage NRK cells, kidney, 
liver, and cardiac endothelial cells from newborn rat, and on 
adult rat uterine epithelium. 
Cardiac muscle was the only other source of  cells examined 
that was found uniformly to exhibit H36 antigen. Cultures of 
cardiac myocytes were prepared from the ventricles of 5-d- 
old rats by trypsinization and  selective plating (21).  These 
cultures were initially composed primarily of characteristic 
stellate-shaped myocardial cells and relatively few, but rapidly 
replicating, endothelial cells. The myocardial cells exhibited 
spontaneous contraction within 24 h  of plating, and myofi- 
brillar banding was detected on subsequent days. IF with H36 
antibody was seen only on the myocardial cells: endothelial 
cells  are  clearly void of this  antigen  (Fig.  2).  In  contrast, 
primary explants of smooth muscle from newborn rat aorta, 
duodenum, and stomach did not react with H36 antibody. 
Secondary cultures were highly enriched for smooth muscle 
cells, as evidenced by their reactivity with purified muscle- 
specific B4 monoclonal anti-actin antibody (Fig.  2). Only a 
few cells exhibited faint IF with H36 antibody, and this was 
evident only with the high-resolution 1.4 numerical aperture 
63x oil lens. Neurites grown from preparturition (day 20) rat 
brain were also generally negative for H36, even though some 
faint IF of H36 was detectable on glial cells with the 63  x 
lens. The uniform, intense reactivity characteristic of skeletal 
muscle was not evident on any of  these cells. Thus, expression 
of H36 antigen apprears to be highly restricted to differentiat- 
ing skeletal muscle and cardiac muscle cells. 
Quantitation  and Distribution  of H36  Antigen 
Both the amount and topographic distribution of H36 on 
the surface of differentiating myoblasts appear to be devel- 
opmentally regulated.  We  have  previously shown that  the 
morphologic development of E63 myoblasts can be followed 
by phase contrast microscopy (26a).  In this course of devel- 
opment, replicating, fiat,  rhomboid-shaped myoblasts elono 
gate,  align,  and fuse to form multinucleate cells that rapidly 
develop into long fibers.  Fusing myoblasts can be discerned 
in the phase image by the lack of distinct boundaries between 
adjacent cells. Prefusion myoblasts are elongate mononucleate 
cells  distinguished by the integrity of their membrane and 
distinct immunofluorescent configuration on the cell surface, 
The relative amounts of H36 on single cells at distinct stages 
of differentiation were measured by photometric analysis of 
IF. The response of this photometer system is linear over the 
range  of intensities  measured (26a).  Cells  were  seeded  on 
sequential days and processed simultaneously to ensure that 
identical staining conditions were in effect. In these experi- 
ments, fusion began on day 5, and cells in culture from 2-8 
d were scored. As seen in Fig. 3, relatively little H36 is present 
on replicating and aligned E63 myoblasts. There is a marked 
increase in H36 as the cells enter the period of rapid fusion 
and some decrease follows fusion, but abundant antigen does 
remain on fused myotubes. This quantitative profile of H36 
on cells at different stages of development is one of several 
distinct patterns exhibited by different antigens on the cell 
surface during myogenesis (26, 26a). 
KAUFMAN  ET At.  Muscle-specific  Membrane  Antigen  1979 FIGURE  1  Expression of H36 antigen on myogenic rat cells. Live myoblasts were reacted at 20°C with monoclonal antibody H36 
and then with FITC-RAMIg.  (A) Primary  myoblasts from newborn rat limb. H36 is abundant on myoblasts {AI  and A2) and on 
myotubes (A3 and A4) but is not detectable on fibroblasts in the same culture (AI, arrows). (/~) E63 myoblasts.  H36 is present on 
2-d E63 cells (t31 and B2), but it is more abundant on fusing cells and myotubes (B3 and B4). Neofluar 40X objective. Bar, 30 pm. 
H36 undergoes several interesting changes in its distribution 
as the cells develop. Although the amount of H36 is relatively 
constant on replicating and aligned myoblasts, it accumulates 
between confluent aligned ceils (Fig. 4 A). Prefusion myoblasts 
have irregular cell margins that are frequently "blebbed", and 
this is evident in both phase and IF images (Fig. 4, D-F). IF 
on prefusion cells  is distinct from the uniform distribution 
seen on myoblasts: it is very irregular on the upper surface 
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and greatly increased in intensity (Fig. 4 D). On the attached 
surface of myoblasts, H36 is distributed in "stitch-like" aggre- 
gates in linear arrays parallel to the long axis of the cell (Fig. 
4 B). This linear pattern is more pronounced on the attached 
surface of myotubes (Fig. 4 G), and some observations suggest 
that this pattern of organization may undergo transient mod- 
ulation during fusion. H36 becomes relatively sparse on the 
upper surface of myotubes, but it is retained and abundant TABLE  I 
Tissue and Species Specificity of H36 Antigen 
IF 
Cell lines 
L8E63 rat skeletal muscle myoblasts  + 
fu-1, -3, -4, -5, -15 (Developmentally  defec- 
tive, nonfusing mutants of LS) 
L6 rat skeletal muscle myoblasts  + 
Amal02 (nonfusing mutant of L6)  ~* 
Rat-1 rat fibroblasts 
FRECI~ rat fibroblasts 
NRK rat kidney cells 
MM14 mouse myoblasts 
Primary cultures 
Newborn rat: 
Skeletal muscle myoblasts  + 
Skeletal muscle fibroblasts 
Cardiac myoblasts  + 
Cardiac endothelial  cells 
Liver cells 
Kidney cells 
Brain glial cells and neurites 
Duodenum smooth muscle cells 
Stomach smooth muscle cells 
Aorta smooth muscle cells 
Chick embryo skeletal muscle myoblasts 
Human skeletal muscle myoblasts 
* Greatly reduced  in comparison with L6. 
on the attached surface of  these fibers (Fig. 4 G). It is not clear 
whether this asymmetry comes about by the selective loss of 
antigen from one surface or via redistribution from the upper 
to the attached surface of myotubes. Other antigens exhibit a 
variety of distinct surface polarizations (26a).  Upon detach- 
ment of myotubes from coverslips either spontaneously or as 
a consequence of handling, H36 remains as "tracks" on the 
coverslip (Fig. 4, I and J), which suggests that it may function 
in the attachment of the cell to the substratum. 
The relative amounts of H36 on E63 and primary skeletal 
•  myoblasts and myotubes, and on other cell types, were deter- 
mined by IF photometry. Myoblasts explanted from newborn 
rats have approximately twice as much H36 as do E63 myo- 
blasts and about threefold the amount on newborn cardiac 
cells (Table II).  Whereas  indirect  IF assays can  yield such 
relative quantitative data, the number of sites per cell cannot 
be derived since the molar ratio of fluorescein to antibody, 
the number of RAMIg molecules bound per H36 antibody, 
and the extinction coefficient of cell-bound FITC-RAMIg are 
not precisely known. To determine the number of H36 sites 
per cell, the monoclonal antibody was iodinated, and satura- 
tion and competition binding assays were done. 
The number of H36 determinants on E63  myoblasts was 
calculated by reaction of confluent cultures of these cells with 
increasing  amounts  of ~25I-H36 antibody  (Fig.  5).  Specific 
binding of antibody was determined by correcting for non- 
specific  binding  in  the  presence  of excess  unlabeled  H36 
antibody.  Extrapolations  from  the  linear  portions  of  the 
curves indicate the saturation of the determinant on E63 cells 
was achieved at 600 ng antibody/ml. Assuming a  1:1 stoichi- 
ometry between antigen and antibody, we calculate there are 
4.3  x  105 molecules of H36 determinant per E63 cell. Com- 
petition binding assays were done to confirm this determina- 
tion. A constant amount of J25I-H36 antibody and increasing 
amounts of unlabeled antibody were reacted with E63  cells 
(Fig.  5 B) and from the 50% inhibition values obtained, we 
calculate there are 3.7  x  l0  s H36 sites/cell. In an analogous 
experiment, the  intrinsic  association constant  of H36  anti- 
body, Ka, was calculated from the binding of ~25I-H36 anti- 
body to confluent monolayers of E63 myoblasts to be 3.8  x 
108 liters/mol. The antibody and determinant were assumed 
to bind in a  1:1 stoichiometry, and concentrations of free and 
bound antibody were determined at subsaturating amounts 
of antibody. 
Chemical Characterization of H36  Antigen 
In search of clues as to the chemical nature of H36 antigen, 
we treated cells with a variety of enzymes, or extracted with 
different reagents. None of the eight proteases (trypsin, chy- 
motrypsin, pronase, papain, dispase, proteinase K, chlostri- 
pain, collagenase) used appeared to diminish the reaction of 
H36  with  its  homologous  antibody.  When  these  enzyme 
treatments  were  carried  out  to  the  extent  that  cells  were 
removed from the coverslips, the suspended cells also specif- 
ically bound H36 antibody. Areas on the coverslip where cells 
were formerly attached  were evident  from the  presence of 
H36  "tracks" detected  by indirect  IF.  In  most cases,  these 
"tracks" were not in the normal linear "stitch-like" pattern, 
which indicates that the H36 antigen was integrally associated 
with the cell membrane and underwent a redistribution as the 
cell's morphology was altered  in  response to  the  proteases 
(Fig. 4). The anomalous finding that the proteases left much 
H36 on the cell surface, as well as leaving "tracks", suggests 
that the associations of H36 in the membrane on the top and 
bottom of the cell may be distinct. 
Neither phospholipase C or D nor yeast lipase removed the 
H36 determinant, although its rearrangement on the mem- 
brane was noted. Neither the exoglycosidase (B-galactosidase, 
hyaluronidase, neuraminidase, B-glucuronidases, a-mannosi- 
dase, N-acetyl glucosaminidase) nor endoglycosidase F, either 
individually or in combinations, removed H36 from the cell 
surface; nor did alkaline or acid phosphatase, or arylsulfatase. 
Extraction of cells with 0.5  mM EDTA did not remove H36 
antigen, although upon prolonged extraction the cells rounded 
and  detached.  Alterations  in  pH  from  4.5  to  8.0  did  not 
extract the determinant,  nor did hypotonic (0.05  M) or hy- 
pertonic (2.0 M) saline. In contrast, cells extracted with 0.25- 
1.0% Triton X-100,  10 mM CHAPS, 1% octylglucoside, cold 
acetone, or chloroform/methanol (2:1) no longer reacted with 
H36 antibody, and no "tracks" were left as a consequence of 
these extractions. We conclude that the H36 determinant is 
an integral membrane component, and  its association with 
the  cell  membrane is highly dependent  on  the  integrity of 
membrane lipids. 
We have used Western blots, immunoaffinity columns, and 
immunoprecipitation to try to identify H36 antigen in deter- 
gent extracts of ceils. Although these procedures were success- 
ful in identifying known proteins added to cell extracts, none 
were effective in unambiguously resolving H36. The effective 
isolation and identification of H36 required the initial inter- 
action of cells with the antibody, followed by solubilization 
in  detergent and isolation of the antigen-antibody complex 
by immunoaffinity chromatography by use of a  rabbit anti- 
mouse Affi-gel  10 column. As seen in Fig. 6, two polypeptides 
with  apparent  molecular weights  of ~98,000  and  117,000 
were isolated from cells labeled either with ~25I using lactoper- 
oxidase, or by incorporation of [aSS]methionine. 
KAUFMAN ET At.  Muscle-specific  Membrane  Antigen  1981 FIGURE  2  Specificity of H36 antibody. Live cells (A and B) were reacted at 20°C with monoclonal antibody H36 and then with 
FITC-RAMIg. (A) Cardiac cells from 5-d-old rats, cultured for 3 d. IF was observed on myocytes stained with H36 (AI; A2, m) but 
not on endothelial cells in the same preparation (AI, arrows). (B) Cells grown from 6-d-old rat duodenum, seen in phase contrast 
(BI), did not stain with H36 antibody (B2). (C) When fixed cells from the same culture of duodenum (CI) were reacted with B4 
monoclonal antibody to smooth-muscle actin, most exhibited immunofluorescent cables (C2), confirming their smooth muscle 
cell origin. B4 antibody does not react with fibroblasts. Planapochromat 63X objective. Bar, 20/~m. 
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FIGURE  3  Quantitation  of  H36  antigen  by  IF  photometry.  E63 
myoblasts were grown for 2-8 d on gelatin-coated  coverslips and 
processed  simultaneously for  IF,  by  reaction at  5°C,  with  H36 
antibody followed  by FITORAMIg. Intensity was measured with a 
lena microphotometer using a 40X Neofluar objective.  Each point 
represents  the  mean  of  at  least  30  measurements on  different 
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Association of H36 with the Cell Cytoskeleton 
We have previously shown that the association of muscle 
membrane antigens with the Triton-insoluble cell framework 
can  be  modulated  by cross-linking  of cell  surface  antigens 
with antibodies  (25). Although most H36  antigen is readily 
extracted with  1%  Triton  X-100,  the determinant  becomes 
refractory to extraction with detergent subsequent to reaction 
of  the cells with primary and secondary antibodies (Table III). 
individual cells, ___ standard  error. A field within the cell boundary 
with a diameter of ~20-22 ~.m was measured. The photometer  was 
zeroed against readings  obtained from cells reacted with SP 2/0- 
Ag-14  culture fluid and  RAMIg.  2 and  3 d  myoblasts (Mb[2]  and 
Mb[3]),  aligned myoblasts (AMb), fusing cells  (F), early myotubes 
(EMt), myotubes (Mt), and late myotubes (LMt) were identified by 
phase contrast microscopy. Prefusion  myoblasts (PMb) were iden- 
tified by characteristic fluorescence. FiGure 4  Distribution of H36 antigen on E63 myoblasts. Live E63 cells were reacted at 5"C with H36 antibody and then with 
FITC-RAMIg. The distributions of H36 on the top and attached surfaces of these cells are distinct.  In contrast to the topography 
of H36 depicted in A,  H36 on the attached surface of these cells appears in "stitch-like" parallel arrays of long aggregates (B). 
H36 accumulates  between aligned confluent myoblasts (A). (C) Phase-contrast image of cells shown  in A and B. Before fusion, 
H36 becomes more abundant on the upper surface of the cell and appears in a more irregular distribution (D), in part due to its 
presence on "blebs" extending from the cell surface (D and E), which persist on early myotubes (emt). Arrows  indicate blebbed 
outline. Blebs are observed by phase contrast  microscopy as phase-dense particles (F, arrows). Linear arrays of H36 persist on 
the attached surface of myotubes (G; H, mt) and tracks (tr)  left by detached myotubes reflect this distribution (I). (J) Phase-contrast 
image of field shown in I. Trypsin treatment of myoblasts causes cell detachment but leaves residual tracks of H36 antigen (K). 
(L) Phase-contrast image of field shown in K. Planapochromat 63X objective. Bar, 20/~m. 
H36  antibody  alone  is  relatively ineffective in  promoting 
cross-linking,  presumably because of the  distance between 
antigen molecules and/or the relative rigidity of this  IgG1 
antibody. The crosslinking achieved by subsequent reaction 
with RAMIg appears to be required to promote the association 
of H36  with  the  Triton-insoluble cytoplasmic framework. 
This supports the earlier stated premise that cell surface H36 
and the monoclonal antibody bind with a  1:1 stoichiometry. 
Expression of H36 is Effected by Inhibitors 
of  Myogenesis 
Incorporation of BrdUrd into DNA inhibits the morpho- 
logic  and  biochemical differentiation of myoblasts (6,  46). 
Similarly, calcium is required for myoblast fusion (29, 43). In 
rat cells, calcium is also required for the expression of other 
parameters of the differentiated phenotype (29, 44), although 
conflicting results  have  been  reported  (47).  We  therefore 
reasoned that if the increased expression of H36 is part of the 
overall unfolding of myogenic development, then inhibition 
of myogenesis with BrdUrd or calcium deprivation should 
alter expression of  H36. Alternatively, if  the H36 determinant 
is unrelated to myogenic development, neither BrdUrd nor 
lowered  calcium  would  affect the  expression  of H36.  To 
ensure  uniformity  in  the  IF  assays,  cells  were  plated  on 
consecutive days and  simultaneously processed for IF and 
determination of fusion and creatine kinase activity. As seen 
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Quantitation of H36 Antigen by Fluorescence Photometry 
Photometry units 
N  ~+SD 
Primary newborn myoblasts  30  42.93 __+ 8.42 
Primary newborn myotubes  30  69.83 _+ 13.42 
Primary newborn fibroblasts  30  0.40 +  0.53 
E63 myoblasts  30  21.23 __ 1.88 
E63 myotubes  24  44.30 _  14.80 
Cardiac myocytes  30  13.70 +  3.96 
Cardiac endothelial cells  24  0.15 __+ 0.80 
Cells  were prepared  and  assayed  for  H36  antigen  by  IF  as  indicated  in 
Materials  and  Methods.  N,  number of cells  scored.  R _  SD, the  mean __. 
standard  deviation. The photometer was zeroed against  readings  obtained 
from each cell type reacted with SP 2/0-Ag14 culture fluid and FITC-RAMIg. 
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FIGURE  5  Quantitation of H36 antigen by radioimmunoassay. (A) 
E63 myoblasts were reacted with increasing concentrations of lZSl- 
H36 antibody. The specific binding of labeled antibody (A  @) 
was determined by  subtracting the  nonspecific  binding  that  oc- 
curred  in  the  presence  of  100  /~g/ml  unlabeled  H36  antibody 
(~)  from the total 12SI-H36 bound in the absence of unlabeled 
antibody (O  O). The linear increase and plateau portions of the 
specific binding curve were extrapolated (dashed line); the inter- 
section of these lines indicates that saturation was achieved at 600 
ng H36 antibody/ml. (B) E63 myoblasts were reacted with increasing 
amounts of unlabeled H36 antibody and a fixed concentration of 
12SI-H36 (50  ng  antibody/lO0  /~1  per  well).  The  number  of  H36 
determinants per cell was calculated from the amount of unlabeled 
H36  antibody  needed to  inhibit  binding of  50%  of the  ~2SI-H36. 
This can be readily determined from a plot of the inverse of percent 
of maximum counts bound versus unlabeled H36 added (inset). A 
value of 0.02 corresponds to 50% inhibition, which occurred at 42 
ng H36 antibody/well. By determining the amount of H36 antibody 
bound to the cells under saturating conditions and the number of 
cells  per  well,  the  number  of  H36  determinants  per  cell  was 
calculated to be 4.3 x  I0  s in A and 3.7 x  10  s in B. 
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FIGURE  6  SDS polyacrylamide get etectrophoresis of H36 antigen. 
E63  cells were labeled with  [3SS]methionine or  12Sl, reacted with 
H36  antibody, and  extracted  in  CHAPS.  The  extract was  serially 
passed through Affi-gel 10, Affi-gel  10-mouse IgG, and Affi-gel 10- 
RAMIg columns. The bound materials were eluted and rebound to 
the  respective  columns  of  origin,  as  indicated  in  Materials  and 
Methods. Samples were concentrated, electrophoresed in  7-20% 
polyacrylamide gradient gels  in  SDS-Tris-glycine  buffer  (30),  and 
autoradiographed. 14C-labeled  myosin  heavy chain (210 K), phos- 
phorylase B (92.5  K),  BSA (68 K), actin (43 K), carbonic anhydrase 
(30  K),  and  cytochrome  C  (12.3  K) were  included  in  aliquots of 
samples run  in  parallel  lanes  (K,  kilodattons).  [~SS]methionine-[a- 
beled proteins which bound to Affi-gel  10 and Affi-gel  lO-lgG are 
visualized in lanes  I  and 2, respectively. The 3ss  (lane 3) and  12sl 
(lane 4)-labeled proteins that repeatedly bound to the RAMIg col- 
umns  contained  proteins  with  apparent  molecular  weights  of 
117,000  and  98,000,  and  these  are  specifically  absent  from  the 
eluates of the control columns. 
TABLE Ill 
Effect of Antibody on Extraction of H36 with Triton X- 100 
Percent 
Protocol  IF  Radioimmunoassay 
Percent 
Soluble  Insoluble  insoluble 
cpm 
Tx-1 °-2 °  9  --  8,786  7 
l°-Tx-2 °  10  122,694  14,131  10 
1  °-2°-Tx  79  16,717  105,725  86 
IF photometry and  radioimmunoassay  were done  in  myoblasts  grown  on 
coverslips for 2 d. The percent IF values given are referenced to unextracted 
controls and background values obtained with SP 2/0 culture fluid have been 
subtracted. The mean cpm from three coverslips are indicated; 126,575  cpm 
bound to  unextracted  cells and was the  value  upon  which  the  percent 
insoluble cpm was determined in the first protocol. Tx, extraction with Triton; 
1  °, H36 monoclonal antibody; 2 °, RAMIg. z  40,  I A~ 
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FIGURE  7  Inhibiton of myogenesis and expression of H36 by low 
calcium. 2.75  x  10  s E63 cells/60-mm dish were seeded on gelatin- 
coated 18-mm coverslips. On day 4, the cells were washed twice 
with calcium-free PBS and then grown in  DME containing 90 #M 
Ca  +2, or in the same medium supplemented with 1,800 #M Ca  +2. 
The same media were replaced on day 6, or, where indicated by 
the dashed line, cells previously grown in 90 pM Ca  +2 were switched 
to  medium containing  1,800  pM  Ca  +2.  To  ensure  uniformity of 
the assays, cells were plated on  sequential days  so that all anal- 
yses could be done on cells processed at the same time. (A) Fluores- 
cence photometry of H36 on  myoblasts grown in  1,800 pM Ca  +2 
(O  O),  90  #M  Ca  +2  (@-~O),  and  in  90 pM,  then  1,800  pM 
Ca  ÷2  (O  O).  The  mean  values  of  at  least  30  determinations 
are  given.  (B)  Fluorescence  photometry  of  H36  on  myotubes 
(I-I  FI) that developed from  myoblasts (O) grown in  1,800 pM 
Ca  +2, or on myotubes (r-i  ....  r-I) that developed upon addition of 
1,800 pM Ca  +2 to myoblasts (0) previously grown in  low calcium. 
(C) Fusion and (D) creatine kinase activity in cultures grown in 1,800 
#M Ca  +2 (O  O), 90 pM Ca  +2 (Q--~O), and in 90 #M Ca  +2, then 
1,800 #M Ca  +2 (O---O). 
expression is.increased just before fusion. H36 is not extracted 
from the cell membrane by either high or low salt, nor by low 
pH, nor by treatment with a variety of enzymes: we therefore 
conclude  that  it  is an  integral  membrane component.  Ap- 
proximately 4  x  105  determinants  are  present  per  cell  in 
subconfluent cultures.  The reactivity of H36 antibody with 
cells is not reduced by prior extensive absorption with HS, 
and therefore the reactivity of this antibody with the cell is 
not due  to the  association with any component of serum. 
Isolation  of [3SS]methionine-labeled  H36  antigen  confirms 
that H36 is a protein synthesized by the cell. 
H36 antigen is extracted, or denatured, by organic solvents 
and detergents; its isolation therefore necessitated reaction in 
situ with the monoclonal antibody, followed by solubilization 
and isolation of  the antigen-antibody complex. Two polypep- 
tides with apparent molecular weights of 117,000  and 98,000 
were thereby isolated using a rabbit anti-mouse immunoglob- 
ulin affinity column and identified by SDS polyacrylamide 
gel electrophoresis. This is the first report of  a developmentally 
regulated protein of this size on the surface of myogenic cells. 
A  105,000-mol-wt protein has been reported to undergo an 
increase in  phosphorylation of L6  myoblasts (39,  40),  and 
two polypeptides with apparent molecular weights of 110,000 
and 98,000 are phosphorylated on the membrane of mutant 
Amal02 cells, but not on wild type L6 myoblasts (40). 
Several lines of evidence suggest that  expression of H36 
antigen is part of the muscle-specific developmental pheno- 
type.  H36  is not  expressed on  any of the  developmentally 
defective fu- mutants of  the L8 line that we previously isolated 
(22,  23),  and its expression on the Amal02 developmentally 
defective mutant of L6 myoblasts is also markedly reduced. 
In addition to not fusing, the fu- lines are, in contrast with 
in Figs.  7 and 8, both 3  x  10  -5 M  BrdUrd and the lowering 
of the  calcium  concentration  to  90  pM  inhibited  fusion, 
creatine kinase activity, and expression of  H36. The inhibition 
of myogenesis effected by lowering the calcium concentration 
was reversible. Within 24 h after addition of calcium to the 
medium, the transient increase in H36 on myoblasts and its 
concomitant  increase  on  myotubes, as  well  as  fusion  and 
creatine kinase activity, paralleled that seen earlier in control 
cultures (Fig. 7). In contrast, removal of BrdUrd did not lead 
to increased expression of H36 nor the other characteristics 
of myogenic development within 48  h.  The lack of reversal 
upon  removal of BrdUrd  is likely due  to the  fact that the 
analogue was incorporated over several generations, and when 
the drug was removed, no further cell replication took place. 
Expression of H36 on myoblasts grown in BrdUrd was con- 
sistently less than that on control cells. Interestingly, although 
fusion was drastically inhibited by growth in BrdUrd, the level 
of H36  on  the  few  myotubes  that  did  form  under  these 
conditions was equivalent to that on normal prefusion myo- 
blasts (Fig.  8 A). 
DISCUSSION 
The use of IF photometry with monoclonal antibodies allows 
the detection  of single molecular species on individual cells 
at distinct stages of development. A monoclonal antibody has 
been  raised  and  used  to  define  a  species-specific,  muscle- 
specific cell-surface antigen.  IF photometry of H36  on  rat 
skeletal myoblasts indicates that this antigen is present at a 
basal  level  on  replicating  and  aligned  myoblasts,  and  its 
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FIGURE  8  Inhibition  of  myogenesis and  expression  of  H36  by 
BrdUrd. E63 cells were plated and processed as in Fig. 7. On days 
2 and 4, the medium was supplemented with 3 x  10  -s M  BrdUrd 
where indicated. Some cultures grown in BrdUrd were switched to 
normal medium on  day 6.  (A)  Fluorescence  photometry of  H36 
antigen on  control  myoblasts (O  O)  and  myotubes (I-1  D), 
and on  myoblasts grown in  BrdUrd (O~--i).  The few myotubes 
that developed in  BrdUrd were scored on  days  5 and  7 (11). (B) 
Fusion (O, O) and creatine kinase activity (A, A) in control cultures 
(O  O, A  A); cells grown in BrdUrd (O~-@, •  •); cells 
grown in BrdUrd and then in control medium (OH-O, A_HA). 
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characteristics of  the differentiated phenotype (23). Treatment 
of fu- cells with trypsin did not reveal "cryptic" H36.  The 
Amal02 mutant has both wildtype and an a-amanitin resist- 
ant,  structurally altered  RNA  polymerase II  (7,  45).  The 
mutant polymerase functions normally with regard to house- 
keeping transcription, however it appears that it cannot tran- 
scribe those genes that are developmentally regulated (8, 45). 
The biochemical and  morphologic differentiation of myo- 
blasts  are also inhibited by growth in low concentrations of 
BrdUrd.  Such  treatment likewise  inhibited the  normal  in- 
creased expression of H36 on myoblasts as well as fusion and 
creatine kinase activity. E63 cells  express only the muscle- 
specific MM isoform of creatine kinase (29).  Similarly, low 
calcium reversibly inhibits development of  the myogenic phe- 
notype and the developmentally regulated expression of H36. 
These experiments with developmentally defective mutants 
and inhibitors of myogenesis indicate that expression of H36 
is a developmentally  regulated characteristic of  skeletal muscle 
differentiation. 
H36 is almost completely extracted from the cell membrane 
by a  variety of detergents. A  small  quantity of detergent- 
insoluble H36 has been determined by electron microscopy 
to be associated with microfilaments (Goff, J., and S. Kauf- 
man,  unpublished  observations).  Furthermore,  binding  of 
H36  antibody to  the  cell surface  increases the  amount  of 
antigen that is insoluble in Triton, in a time and temperature- 
dependent fashion (Lowrey, A., and S. Kaufman, unpublished 
observations). The inextractability of the antigen in detergent 
and its association with cytoskeletal filaments is enhanced by 
reaction  with  secondary  antibody.  Previous  studies  have 
shown that cross-linking by bivalent antibody is required to 
promote such  membrane-cytoskeletal associations (13,  25, 
28).  This inducible association of cell surface H36 with the 
cell cytoskeleton substantiates the conclusion that H36 is an 
integral  membrane component.  Cross-linking  of H36  also 
promotes its aggregation and concomitant localized clearing 
from the cell surface. Such localized clearings may also come 
about through cell-cell interactions, and the potential conse- 
quences of this to cell fusion have been previously discussed 
(24). 
The  accumulation  of  H36  antigen  between  confluent, 
aligned  myoblasts and  its  presence on  membrane  "blebs" 
suggests that the alteration in the spatial distribution of H36 
is part of the membrane remodeling that accompanies devel- 
opment. Purified membrane blebs isolated from differentiat- 
ing myoblasts have recently been reported to promote the 
fusion of a  nonfusing mutant (9), and thus these structures 
appear to be significant in myoblast fusion. 
The distributions of H36 on the top and attached surfaces 
of the cell are distinct. The relevance of this asymmetry, and 
the mechanisms by which distinct distributions and selective 
retention are  established,  are  unknown.  Although  the  cell 
culture dish is far removed from the in vivo environment, it 
is likely that in vivo associations of cells, with each other or 
with extracellular components, may promote or require lo- 
calized specializations on the cell membrane. Thus, the asym- 
metry of H36 in the membrane of cells  in  culture may be 
indicative  of the  capacity  of cells  to  establish  subcellular 
specializations in vivo. 
Monoclonal antibodies have recently been used to describe 
a variety of events on the surface of differentiating myoblasts 
(17,  25,  31, 49).  Our combined applications of radioimmu- 
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noassays and  microscopic fluorescence photometry of anti- 
gens on single cells have demonstrated that both topographic 
and quantitative alterations occur on the surface of differen- 
tiating myoblasts, that the membrane is in a dynamic state, 
and that a dramatic remodeling of the myoblast membrane 
accompanies development (25, 26a).  Several components of 
the extracellular matrix associated with skeletal  muscle have 
also been defined by monoclonal antibodies (1, 4, 5,  l 1, 50) 
as  have  antigens  that  are  present  on  both  myoblasts  and 
satellite  cells  (18,  48).  For the most part, the structure and 
function of  these antibody-defined  components have not been 
determined. Two antibodies that disrupt the attachment of 
myoblasts to their substratum  have been reported (16,  35), 
and  an  antibody reactive with  the  sodium  and  potassium 
stimulated ATPase has been used to quantitate this membrane 
enzyme (12). 
The expression of several molecular species  common to 
muscle and  many other cell types appears  to  be develop- 
mentally regulated during myogenesis, e.g., thy-1 (32) OKTK- 
9 (5 l), flbronectin ( 14, 31), and others (3 l, 51). The expression 
of yet other antigens is restricted to muscle and to one or 
more additional cell types (12,  35,  48,  5 l). Although some 
antigens on myoblasts have been reported to be less abundant 
or absent on one type of nonmuscle cell, the degree to which 
expression of these antigens is restricted to muscle has not 
been  determined  (17,  18,  51).  In  those  cases  when  more 
extensive testing for cell specificity has been done, develop- 
mentally regulated components on myoblasts have also been 
found on other cell types (12, 31, 45). With the exception of 
the acetylcholine receptor, H36 is the only membrane antigen 
reported to date that has undergone extensive testing and that 
has been shown to be muscle-specific.  Analysis of H36 on a 
variety of cell types demonstrated that expression of H36 is 
restricted to cardiac and skeletal muscle. Cells that have at 
least 100-fold less H36 on their surface fall below our limit of 
detection by fluorescence photometry and have been cited as 
negative for H36 (Table II). Radioimmunoassays indicate that 
there are -4  ×  l05 H36 determinants per myoblast in sub- 
confluent cultures (Fig. 5), and analogous experiments (data 
not shown) indicate that there are <200  H36 determinants 
per developmentally defective fu-1  cell.  H36 is  present on 
fetal rat myoblasts and on myogenic lines derived from these, 
and on juvenile (4 wk) myotubes (Cameron, J., and S. Kauf- 
man, unpublished observations). The restriction of H36 an- 
tigen to cardiac and skeletal  muscle should prove useful in 
identifying and isolating cells of both the cardiac and skeletal 
myogenic lineages. 
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